These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16000935)

  • 1. Hepatic injury in a patient taking rosiglitazone.
    Menees SB; Anderson MA; Chensue SW; Moseley RH
    J Clin Gastroenterol; 2005 Aug; 39(7):638-40. PubMed ID: 16000935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
    Osei SY; Koro CE; Cobitz AR; Kolatkar NS; Stender M
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1244-6. PubMed ID: 19655316
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosiglitazone and pioglitazone in the treatment of diabetes mellitus.
    Odom J; Williamson B; Carter L
    Am J Health Syst Pharm; 2008 Oct; 65(19):1846-50. PubMed ID: 18796427
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.
    Beiderbeck AB; Sakaguchi M
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1247-9. PubMed ID: 19842093
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosiglitazone and cardiovascular risk: weighing recent evidence.
    Stafylas PC; Sarafidis PA; Lasaridis AN
    J Cardiometab Syndr; 2007; 2(4):295-6. PubMed ID: 18059214
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.
    Bonkovsky HL; Azar R; Bird S; Szabo G; Banner B
    Dig Dis Sci; 2002 Jul; 47(7):1632-7. PubMed ID: 12141828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Options sought after drug study. Patients who take rosiglitazone might consider pioglitazone instead.
    Heart Advis; 2007 Jul; 10(7):9. PubMed ID: 17703512
    [No Abstract]   [Full Text] [Related]  

  • 8. Case series of liver failure associated with rosiglitazone and pioglitazone.
    Floyd JS; Barbehenn E; Lurie P; Wolfe SM
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1238-43. PubMed ID: 19623674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinedione-induced edema in patients with heart failure.
    Stroup JS
    Am J Health Syst Pharm; 2007 Dec; 64(23):2426-30; author reply 2430. PubMed ID: 18029947
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
    Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
    [No Abstract]   [Full Text] [Related]  

  • 11. Second-generation thiazolidinediones and hepatotoxicity.
    Marcy TR; Britton ML; Blevins SM
    Ann Pharmacother; 2004 Sep; 38(9):1419-23. PubMed ID: 15266041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long Avandia endgame.
    Mullard A
    Lancet; 2011 Jul; 378(9786):113. PubMed ID: 21748869
    [No Abstract]   [Full Text] [Related]  

  • 13. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
    Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular safety of rosiglitazone.
    Krall RL
    Lancet; 2007 Jun; 369(9578):1995-1996. PubMed ID: 17574083
    [No Abstract]   [Full Text] [Related]  

  • 15. The rosiglitazone controversy: the Indian perspective.
    Mohan V; Joshi SR
    J Assoc Physicians India; 2007 Jul; 55():477-80. PubMed ID: 17907495
    [No Abstract]   [Full Text] [Related]  

  • 16. Rosiglitazone and cardiovascular risk.
    Brett AS
    N Engl J Med; 2007 Aug; 357(9):939; author reply 939-40. PubMed ID: 17806134
    [No Abstract]   [Full Text] [Related]  

  • 17. Pioglitazone is a valid alternative to rosiglitazone.
    Derosa G
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):357-62. PubMed ID: 21950735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of rosiglitazone exposure in the second trimester of pregnancy.
    Kalyoncu NI; Yaris F; Ulku C; Kadioglu M; Kesim M; Unsal M; Dikici M; Yaris E
    Reprod Toxicol; 2005; 19(4):563-4. PubMed ID: 15749272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Doubts as to the cardiovascular safety of rosiglitazone].
    Hoekstra JB; Bossuyt PM; de Vries JH
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1449-50. PubMed ID: 17633972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
    Lenhard MJ; Funk WB
    Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.